4974 On Other Exchanges
Symbol
Exchange
4974 is not on other exchanges.

takara bio inc (4974) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TAKARA BIO INC (4974)
\

Related News

No related news articles were found.

takara bio inc (4974) Related Businessweek News

No Related Businessweek News Found

takara bio inc (4974) Details

Takara Bio Inc. operates as a biotechnology company in Japan and internationally. It operates through Bio Industry, Gene Therapy, and AgriBio segments. The company develops original research reagents and scientific instruments; and provides contracted research services that utilize new genetic and cell engineering technologies, which support biotechnology research and bioindustry in fields that range from basic research to drug discovery and development. Its contracted research and production services cover technical support services for cancer immunotherapy and biopharmaceutical development support services. In addition, the company engages in the development of various gene therapies, including HF10 anti-cancer therapy that is in Phase II clinical trials targeting malignant melanoma; siTCR gene therapy, which is in Phase I/II clinical trials for the treatment of esophageal cancer, synovial sarcoma, etc.; and MazF gene therapy, which is in Phase I clinical trials for patients infected with the human immunodeficiency virus. Further, it researches on functional properties derived from traditional Japanese food ingredients; and provides functional food ingredients as raw materials. Additionally, the company provides functional foods, such as Fucoidan from Gagome kombu, Isosamidin from herbs, Chalcone from Ashitaba, Agaro-oligosaccharide from Agar, Yamsgenin from the lesser yam, and Terpene from a mushroom. It also cultivates, produces, and markets various mushroom types, such as Honshimeji, Hatakeshimeji, and Bunashimeji, as well as licenses mushroom production technology. The company was founded in 2002 and is headquartered in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.

1,344 Employees
Last Reported Date: 06/29/17
Founded in 2002

takara bio inc (4974) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

takara bio inc
Takara Bio Inc. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2018

Takara Bio Inc. provided year end dividend guidance for the fiscal year ending March 31, 2018. For the period, the company expected year end dividend of JPY 4 per share compared to JPY 4 per share paid in the same period ago.

Takara Bio Inc. Reports Unaudited Consolidated Earnings Results for Nine Months Ended December 31, 2017

Takara Bio Inc. reported unaudited consolidated earnings results for nine months ended December 31, 2017. For the nine months, the company reported income before income taxes was ¥1,742 million compared to ¥2,625 million a year ago. Net cash provided by operating activities was ¥587 million compared to ¥1,488 million a year ago. Purchase of property plant and equipment and intangible assets was ¥909 million compared to ¥954 million a year ago.

Takara Bio Group Reports Earnings Results for Nine Months Ended December 31, 2017; Provides Earnings Guidance for the Year Ending March 31, 2018

Takara Bio Group reported earnings results for nine months ended December 31, 2017. For the period, the company’s net sales were ¥22,646 million against ¥20,645 million a year ago. Operating income was ¥1,608 million against ¥2,724 million a year ago. Ordinary income was ¥1,762 million against ¥2,869 million a year ago. Net income attributable to owners of the parent was ¥1,068 million against ¥1,561 million a year ago. Net income per share was ¥8.88 against ¥12.97 a year ago. For the year ending March 31, 2018, the company expects net sales of ¥33,000 million, operating income of ¥3,500 million, ordinary income of ¥3,800 million, net income attributable to owners of the parent of ¥2,000 million and net income attributable to owners of the parent per share of ¥16.61.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4974 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4974.
View Industry Companies
 

Industry Analysis

4974

Industry Average

Valuation 4974 Industry Range
Price/Earnings 100.0x
Price/Sales 8.2x
Price/Book 4.3x
Price/Cash Flow 300.9x
TEV/Sales 7.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAKARA BIO INC, please visit www.takara-bio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.